Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Lessened by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,312 shares of the medical equipment provider’s stock after selling 46 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in Intuitive Surgical were worth $2,804,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. J.W. Cole Advisors Inc. boosted its position in Intuitive Surgical by 8.3% during the third quarter. J.W. Cole Advisors Inc. now owns 2,040 shares of the medical equipment provider’s stock valued at $596,000 after purchasing an additional 156 shares during the last quarter. Sage Mountain Advisors LLC grew its stake in shares of Intuitive Surgical by 7.7% in the 3rd quarter. Sage Mountain Advisors LLC now owns 1,253 shares of the medical equipment provider’s stock valued at $366,000 after buying an additional 90 shares in the last quarter. Everhart Financial Group Inc. grew its stake in shares of Intuitive Surgical by 15.6% in the 3rd quarter. Everhart Financial Group Inc. now owns 1,450 shares of the medical equipment provider’s stock valued at $424,000 after buying an additional 196 shares in the last quarter. Pinnacle Wealth Management Advisory Group LLC increased its holdings in Intuitive Surgical by 6.4% in the third quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,479 shares of the medical equipment provider’s stock worth $432,000 after buying an additional 89 shares during the last quarter. Finally, Brighton Jones LLC lifted its stake in Intuitive Surgical by 0.9% in the third quarter. Brighton Jones LLC now owns 8,881 shares of the medical equipment provider’s stock valued at $2,596,000 after acquiring an additional 79 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on ISRG. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a report on Friday, January 19th. Raymond James upped their price target on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Barclays raised their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. BTIG Research upped their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Finally, Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, President David J. Rosa sold 80,710 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $389.28, for a total transaction of $31,418,788.80. Following the completion of the transaction, the president now directly owns 163,399 shares of the company’s stock, valued at approximately $63,607,962.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the sale, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The disclosure for this sale can be found here. Insiders have sold 226,928 shares of company stock valued at $87,833,828 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Up 1.0 %

ISRG traded up $3.71 on Friday, hitting $381.36. 1,028,858 shares of the stock traded hands, compared to its average volume of 1,492,254. The business has a fifty day moving average price of $385.40 and a two-hundred day moving average price of $349.30. The firm has a market capitalization of $135.27 billion, a PE ratio of 68.84, a P/E/G ratio of 4.93 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical’s quarterly revenue was up 11.5% on a year-over-year basis. During the same period in the previous year, the business posted $1.00 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.